Neva Finventures
Corso Castelfidardo 22, Turin, Piemonte, 10128, Italy
Overview
Neva Finventures is Intesa Sanpaolo's Corporate Venture Capital investment vehicle. Neva invests, minority stakes, in fintech companies that have potential synergies with the Group and its activities; Neva is sector agnostic and invests globally (mainly in Europe, Israel and USA). In Italy, it also invests in non-fintech initiatives, supporting the ecosystem, with the ambition to position Intesa Sanpaolo as a strategic partner for startups that intend to penetrate new markets and key industries, focusing on circular economy and data-driven economy. Neva also invests in venture capital funds (FOF).
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- BetaGlue Technologies
Led · Equity · Jun 2024
BetaGlue Therapeutics is a clinical-stage Italian company developing a personalized radiotherapy platform called YntraDose for the treatment of various solid tumors. The company announced an €8 million equity financing led by Neva and LIFTT, with participation from FinPosillipo (Gruppo Petrone), Romed and Giovanni Cerutti. BetaGlue previously secured an EIC Accelerator Award valued at €10 million, of which €7.5 million was equity. Combined with the new round, the company has raised a total of €18 million. The capital will be used to strengthen the team and to accelerate and expand development of the YntraDose platform across multiple oncology indications. CEO Colin Story said the funding will help advance the pipeline toward important development and regulatory milestones. BetaGlue is a Milan-based clinical-stage company developing the BAT-90 platform, a novel medical device technology for loco-regional radiotherapy aimed at unresectable solid tumours. The company is advancing BAT-90 through clinical development across multiple solid tumour indications. Financially, BetaGlue has just secured a €10m EIC Accelerator award composed of a €2.5m grant and a €7.5m equity component to fund further clinical progress. The firm highlights support from a global Scientific Advisory Board and leading national and international advisers. BetaGlue’s leadership frames the EIC award as validation of the platform’s clinical and commercial potential and of the executive team driving development.
- Yolo Tech Insurance
Led · Series A · Jan 2019
Yolo is an insurtech startup headquartered in Milan that enables users to activate micro-insurance policies in real time and pay only for the exact period they need coverage. Its fully digital, paperless platform works on both PC and mobile, making it possible to buy protection for a specific day, week, or event. The company organizes its offering into four verticals: YOLO viaggi (travel), YOLO beni (everyday items), YOLO persone (personal coverage), and YOLO salute (health). All products follow a pay-per-use model designed for flexibility and immediacy. Co-founders Simone Ranucci Brandimarte and Gianluca De Cobelli aim to use the proceeds from their initial funding to accelerate technology and product development. To date, Yolo has secured €1 million in external financing through its first venture capital round.
Team
No current team members are available.